UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB


(Mark One)
            |X|  QUARTERLY REPORT UNDER SECTION 13 OR 15(D)
                 OF THE SECURITIES EXCHANGE ACT OF 1934

                       For the quarterly period ended December 31, 2004

            [ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(D)
                 OF THE EXCHANGE ACT

           For the transition period from ______________ to ______________


                        Commission file number  000-30697


                            PERFECT HEALTH CARE CORP.
           ----------------------------------------------------------
           (Exact name of small business as specified in its charter)


             NEVADA                                     48-1302159
----------------------------------------    ------------------------------------
   (State or other jurisdiction of           (IRS Employer Identification No.)
    incorporation or organization)


                  4017 Colby Avenue, Everett, Washington 98201
          -----------------------------------------------------------
                    (Address of principal executive offices)


                                 (425) 258-4222
                           --------------------------
                           (Issuer's telephone number)


  ----------------------------------------------------------------------------
              (Former name, former address, and former fiscal year,
                         if changed since last report)


                                      -i-
<PAGE>

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.  Yes |X|     No [ ]

                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Check whether the registrant filed all documents and reports required to be
filed by Section 12, 13, or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by the court.   Yes [ ]     No [ ]

                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:

     As of January 1, 2005, 23,511,000 shares common stock, $0.001 par value

Transitional Small Business Disclosure Format (Check one):  Yes  [ ]    No  |X|

                                      -ii-
<PAGE>

                         PART 1 - FINANCIAL INFORMATION

Item 1  -  Financial Statements

In the opinion of management, the accompanying unaudited financial statements
included in this Form 10-QSB reflect all adjustments necessary for a fair
presentation of the results of operations for the periods presented. The results
of operations for the periods presented are not necessarily indicative of the
results to be expected for the full year.





                                      -1-
<PAGE>

                            PERFECT HEALTH CARE CORP.
                                  Balance Sheet
                                   (Unaudited)

<TABLE>
<CAPTION>
           Assets
                                                        December 31,     June 30,
                                                            2004           2004
                                                        --------------------------
Current Assets

<S>                                                          <C>         <C>
      Cash and cash equivalents                              $ 1,790     $ 27,872
      Accounts receivable, net of allowance
           for doubtful accounts                              20,116       41,343
      Prepaid expenses                                           999        1,440
                                                        -------------  -----------
                            Total Current Assets              22,905       70,655


Property and Equipment

      Office furniture and equipment                          14,229       13,729
      Vehicles                                                 6,064        6,064
      Leasehold improvements                                   8,611        7,703
      Less - accumulated depreciation                         (7,294)      (5,486)
                                                        -------------  -----------
                      Net Property and Equipment              21,610       22,010

           Total Assets                                     $ 44,515     $ 92,665
                                                        =============  ===========

      Liabilities and Stockholders' Equity (Deficit)

Current Liabilities

      Accounts payable and accrued liabilities             $ 127,780     $ 87,553
      Deferred revenue                                        41,466       58,043
      Accrued compensation                                   110,450       83,450
      Advances by stockholders and directors                 372,723      273,578
                                                        -------------  -----------
                       Total Current Liabilities             652,419      502,624

Stockholders' Equity (Deficit)

      Preferred stock
           $.001 par value; 25,000,000
              shares authorized, 1,600,000
              shares issued and outstanding                    1,600        1,600
      Common Stock
           $.001 par value; 200,000,00
              shares authorized, 23,511,000 and
              23,066,000 shares issued and outstanding
              at June 30, 2004 and 2003, respectively         23,511       23,511
      Additional Paid-in Capital                             611,189      611,189
      Less stock subscriptions receivable                     (7,500)      (7,500)
      Retained earnings (deficit)                         (1,236,704)  (1,038,759)
                                                        -------------  -----------
Total Liabilities and Stockholders' Equity (Deficit)        (607,904)    (409,959)
                                                        -------------  -----------
                Total Stockholders' Equity (Deficit)        $ 44,515     $ 92,665
                                                        =============  ===========
</TABLE>


              See accompanying notes to the financial statements.


                                      -2-
<PAGE>

                            PERFECT HEALTH CARE CORP.
                            Statements of Operations
                                   (Unaudited)


<TABLE>
<CAPTION>
                                                  Three months      Three months     Six months     Six months
                                                      ended             ended           ended         ended
                                                  Dec 31, 2004      Dec 31, 2003    Dec 31, 2004   Dec 31, 2003
                                               ----------------- ----------------  -------------- ---------------

<S>                                                    <C>              <C>             <C>             <C>
Revenue from Card Sales                                $ 10,040         $ 13,460        $ 29,432        $ 46,557

Cost of Card Sales                                        6,800           15,262          22,317          26,529
                                               ----------------- ---------------- --------------- ---------------

Gross Profit                                              3,240           (1,802)          7,115          20,028

Expenses
   Selling, general and administrative expense           92,781          262,148         203,252         512,434
   Depreciation                                             904            1,130           1,808           2,260
                                               ----------------- ---------------- --------------- ---------------

                                Total Expenses           93,685          263,278         205,060         514,694

                                      Net Loss        $ (90,445)      $ (265,080)     $ (197,945)     $ (494,666)
                                               ================= ================ =============== ===============


Net Loss per Common Share                               $ (0.00)         $ (0.01)        $ (0.01)        $ (0.02)
                                               ================= ================ =============== ===============

Weighted Average Common Shares Outstanding           23,511,000       23,312,749      23,511,000      23,340,167
                                               ================= ================ =============== ===============
</TABLE>



              See accompanying notes to the financial statements.



                                      -3-
<PAGE>

                            PERFECT HEALTH CARE CORP.
                            Statements of Cash Flows
                                   (Unaudited)



<TABLE>
<CAPTION>

                                                           Three months      Three months     Six months     Six months
                                                               ended             ended           ended         ended
                                                           Dec 31, 2004      Dec 31, 2003    Dec 31, 2004   Dec 31, 2003
                                                        ----------------- ----------------  -------------- ---------------
Operating Activities
<S>                                                            <C>             <C>              <C>            <C>
    Net Loss                                                   $ (90,445)      $ (265,080)      $ (197,945)    $ (494,666)
      Adjustments to reconcile net loss to cash used
         by operating activities:
         Depreciation                                                904            1,130            1,808          2,260
         Provision for bad debts                                       -                -                -              -
         Preferred stock issued for services rendered                  -                -                -              -
         Changes in operating assets and liabilities
           (Increase) decrease in accounts receivable             14,848           (7,758)          21,227           (504)
           (Increase) decrease in prepaid expenses                     -              920              441          4,456
           Increase (decrease) in accounts payable
              & accrued liabilities                               14,520          105,760           40,227        104,444
           Increase (decrease) in accrued compensation            13,500           29,265           27,000         56,875
           Increase (decrease) in advance by
              stockholders/directors                                   -            8,470           (6,855)        17,061
           Increase (decrease) in deferred revenue                     -            5,568          (16,577)        (8,747)
                                                          ---------------   --------------   --------------  -------------
                       Cash used by Operating Activities         (46,673)        (121,725)        (130,674)      (318,821)

Investing Activities
    Purchase of property and equipment                              (500)               -           (1,408)        (2,062)
                                                          ---------------   --------------   --------------  -------------

                      Net cash from Investing Activities            (500)               -           (1,408)        (2,062)

Cash Flows from Financing Activities
      Proceeds from sales of common stock                              -                -                -              -
      Payments of stock subscriptions, net                             -                -                -         65,000
      Advances by stockholders/directors                          33,000           10,000          106,000         10,000
                                                          ---------------   --------------   --------------  -------------

                      Net cash from Financing Activities          33,000           10,000          106,000         75,000
                                                          ---------------   --------------   --------------  -------------

Net increase (decrease) in cash                                  (14,173)        (111,725)         (26,082)      (245,883)

Cash at beginning of period                                       15,963          112,358           27,872        246,516
                                                          ---------------   --------------   --------------  -------------

Cash at end of period                                            $ 1,790            $ 633          $ 1,790          $ 633
                                                          ===============   ==============   ==============  =============


Cash paid for income taxes                                           $ -              $ -              $ -            $ -
                                                          ===============   ==============   ==============  =============

Cash paid for interest                                               $ -              $ -              $ -            $ -
                                                          ===============   ==============   ==============  =============
</TABLE>


              See accompanying notes to the financial statements.


                                      -4-
<PAGE>

                            PERFECT HEALTH CARE CORP.

                          NOTES TO FINANCIAL STATEMENTS

                                December 31, 2004


A.  BASIS OF PRESENTATION

The Interim financial statements of Perfect Health Care Corp. (the Company) for
the three and six months ended December 31, 2004 are not audited. The financial
statements are prepared in accordance with the requirements for unaudited
interim periods, and consequently do not include all disclosures required to be
in conformity with accounting principles generally accepted in the United States
of America.

In the opinion of management, the accompanying financial statements contain all
adjustments, consisting only of normal recurring accruals, necessary for a fair
presentation of the Company's financial position as of December 31, 2004 and the
results of operations and cash flows for the three and six months ended December
31, 2004.

The results of operations for the three and six months ended December 31, 2004
are not necessarily indicative of the results for a full year period.



B.  SIGNIFICANT ACCOUNTING POLICIES

(a)      Accounting methods

These consolidated financial statements were prepared on an accrual method of
accounting.

(b)       Use of Estimates

The preparation of consolidated financial statements in conformity with
generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amount of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.

(c)      Revenue Recognition

The Company sells the Card either through annual contracts with customer payment
due at the time the contract is executed or on a month-to-month basis with
payment due each month. Revenue from the sale of annual contracts is deferred
and recognized on a straight line basis over the contractual term. Revenue
related to month-to-month agreements is recognized as payments are received from


                                      -5-
<PAGE>

the customers. Customers have the right to a refund of only their unamortized
portion of the annual contract. Month-to-month agreements have no refund rights.

(d)      Loss Per Share

Loss per share is based on the weighted average number of shares outstanding
during the period. The Company adopted SFAS No. 128, "Earnings Per Share."

(e)      Income Taxes

The Company has adopted SFAS No. 109 "Accounting for Income Taxes". The Company
accounts for income taxes under an asset and liability approach that requires
the recognition of deferred tax assets and liabilities for the expected future
tax consequences of events that have been recognized in the Company's financial
statements or tax returns.

In estimating future tax consequences, all expected future events, other than
enactment of changes in the tax laws or rates, are considered.

Due to the uncertainty regarding the Company's future profitability, the future
tax benefits of its losses have been fully reserved and no net tax benefit has
been recorded in these financial statements.

(f)      Fair Value of Financial Instruments

The respective carrying value of certain on-balance-sheet financial instruments
approximated their fair values. These financial instruments include cash, tax
credit recoverable, reclamation bond, loan receivable, accounts payable and
accrued liabilities, amount due to a director and loan payable. Fair values were
assumed to approximate fair values or they are receivable or payable on demand.
Management is of the opinion that the Company is not exposed to significant
interest, credit or currency risks arising from these financial instruments.


Item 2  -  Management Discussion and Analysis

         The following discussion and analysis should be read in conjunction
with our un audited financial statements for the six month period ended December
31, 2004.

Introduction

         We are engaged in the marketing and administration of membership
programs that entitle our members (also called "cardholders") to receive
discounted rates on medical and related products and services when they purchase
for cash without the aid of insurance. Our principal product is the Primary Care
Card which, for a fee of $49 per month, permits the cardholder to obtain
discounts ranging from 5% to nearly 70% off the regular pricing schedules when


                                      -6-
<PAGE>

they purchase services from providers who are members of our provider networks.
Services can include primary care, medical specialists, radiology, physical
therapy, hospitalization, pharmaceutical, prostheses, vision care, chiropractic,
alternative medicine treatments, medical evacuation, patient advocacy, and
others. Other Card products, offered at lesser prices, provide discounts on
varying combinations of services with varying rates of discounts.

         To date, our greatest challenge has been establishing a market for our
offerings. Since inception, we have focused our limited resources largely on
negotiating the provider agreements needed to package what we think are
exceptional products, but we have yet to demonstrate any meaningful degree of
market acceptance for those products. Ongoing discussions with insurance
industry executives have indicated that our Card products may be successfully
"bundled" with conventional insurance products, however we have yet to
consummate such a marketing partnership. Our contract with UIS (see "Item 1 -
Description of Business", above) has yielded some encouraging sales results
marketing the Card as a stand-alone product. And representatives of various
established marketing and sales representative organizations encountered at
trade shows have resulted in some re-seller agreements, but none as yet have had
significant success in marketing our Card products. Our own sales efforts based
on local television and print advertising have yielded some sales, but we
currently lack the resources to exploit these successes.

Results Of Operations For the Six Months Ended December 31, 2004 vs. 2003

         Since our inception, we have funded our activities primarily by issuing
stock and borrowing. Although we will continue periodically to seek external
sources of funds, there can be no assurance that we will be able to raise
sufficient capital to fund our operations. If we do raise equity capital,
depending on the number of shares issued and the issue price of the shares,
current shareholders' interests may be diluted.

         During the fiscal year ended June 30, 2004, our first full fiscal year
of operation, we raised $29,000 from sales of equity stock, and received
$190,000 in advances from officers and directors. The stock sales were sales of
our $.001 par value common stock made without registration under the Securities
Act of 1933 (the "Act"), pursuant to a private placement under Regulation D of
the Act. During the quarter ended September 30, 2004 we received and additional
$73,000 in advances from officers and directors.

         For the quarter ended December 30, 2004 we had revenues of $10,040
versus $13,460 for the same period in 2003. Expenses for the period were $93,685
vs. $263,278, which included accrued executive compensation of $13,500 and
$27,250, respectively. The reductions in both revenues and expenses are
attributable to a scaling back of our administrative staff and direct marketing
activities somewhat as we focus on establishing and further developing reseller
arrangements with established marketing organizations.



                                      -7-
<PAGE>

         The Company's consolidated financial statements were prepared on a
going concern basis, which assumes that the Company will be able to realize
assets and discharge liabilities in the normal course of business. Our
independent auditors included in their report for the period ended June 30, 2004
cautionary language indicating substantial doubt as to the company's ability to
continue as a going concern. The ability to continue as a going concern is
dependent on our ability to generate profitable operations in the future, to
maintain adequate financing, and to achieve a positive cash flow. There is no
assurance we will be able to meet all or any of such goals.

Revenue Recognition Policy

         Currently, all of our Card products are sold as renewable annual
memberships, for which we receive either monthly payments or a discounted
payment in advance for the entire term. Where we receive monthly payments, we
recognize revenue each month as we receive the payments. In the case of pre-paid
memberships, we defer both the revenue and the cost, recognizing them pro-rata
over the succeeding periods for the period of the membership.


Liquidity and Capital Resources

         At December 31, 2004 we had cash and cash equivalents of $1,790 and
accounts receivable (net of allowance for doubtful accounts) of $20,116. We have
reduced our administrative expenses compared to the prior year, but at our
present levels of revenues and expenses we expect our available funds to support
our operations for only about three months into the future. In the past year we
have met our expenses in part through advances from certain directors and
executive officers, but the individuals are not obligated to continue to make
such advances. We have no lines of credit or other sources of cash, and expect
to find it necessary to raise additional capital before during the next twelve
months, probably through a private sale of our common stock. We expect revenues
from our UIS/Quixtar remarketing agreement to continue to increase, although not
to a level sufficient to cover our expenses for the foreseeable future.


Item 3  -  Controls and Procedures

An evaluation was carried out under the supervision and with the participation
of the Company's management, including its Chief Executive Officer and Chief
Financial Officer, of the effectiveness of the disclosure controls and
procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934,
as amended). Based on that evaluation, the Chief Executive Officer and Chief
Financial Officer concluded that the disclosure controls and procedures were
effective as of the end of the period covered by this report.

No change in the Company's internal control over financial reporting (as defined
in Rule 14-15f) of the Securities Exchange Act of 1934, as amended) occurred


                                      -8-
<PAGE>

during the period covered by this report that has materially affected, or is
reasonably likely to materially affect, the Company's internal control over
financial reporting.


                           PART II - OTHER INFORMATION


Item 2  -  Changes in Securities

None

Item 6  -  Exhibits and Reports on Form 8-K


Exhibits

       Exhibit No.                Description
     ----------------      ------------------------------------------------

          31.1             Certification of CEO / CFO (Section 302)
          32.1             Certification of CEO / CFO (Section 302)




                                   SIGNATURES

         In accordance with the requirements of the Exchange Act, the Registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


                                     PERFECT HEALTH CARE CORP.


February 18, 2005                    /s/ Antoine Jarjour
                                     ------------------------------------------
                                     President, Chief Executive Officer




                                      -9-